Abzyme Therapeutics
UEI: H2MLEFWV36N6
• CAGE: 62ES6
Overview
Awardee Type
Parent
Federal Capability Statement
Provide services in recombinant antibody development, modification and production services
Keywords
Biotechnology Research, Therapeutic antibodies, Antibody development, Human antibodies, Camelid single domain antibodies, VHH, bispecific antibodies, blood brain barrier, Cancer, eye diseases, infectious diseases, diagnostic imaging, pre-targeted immunotherapy, in-cell antibody maturation.
Website
Headquarters
Pottstown, PA
United States
United States
Most Recent Award
May 22, 2023
Calculating
Federal contract and grant recipient
ABZYME THERAPEUTICS LLC
(UEI H2MLEFWV36N6, CAGE 62ES6)
is headquartered in Pottstown PA.
The partnership
was founded in June 2010 and
federally registered in
July 2010.
Federal Award Analysis
Abzyme Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ABZYME THERAPEUTICS LLC
UEI
H2MLEFWV36N6
CAGE Code
62ES6
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
Asian-Pacific American Owned
Minority Owned Business
Minority Owned Business
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Assistance Awards
Date Founded
June 22, 2010
Initial Registration
July 5, 2010
Last Registration
Feb. 24, 2025
Registration Activation
Jan. 23, 2025
Registration Expiration
Jan. 21, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
PA
Country of Incorporation
USA
Employees
<500
Reported NAICS
None Reported
Accepts Credit Cards
No